CorEvitas, LLC, Waltham, Massachusetts, United States (Recruiting) - 21 Aug `26Long-term safety registry for vitiligo treatments

Long-term safety registry for vitiligo treatments

Official title: PPDTM CorEvitasTM Vitiligo Drug Safety and Effectiveness Registry for Adults & Adolescents

Status: Recruiting now

Description:

CorEvitas plans to enroll about 2,500 participants. This is an observational study, so researchers will not assign an experimental treatment. Researchers are tracking the long-term safety and real-world results of vitiligo treatments in adults and adolescents. Participants may complete exams, questionnaires, record reviews, imaging, or sample collection; no drug-related side effects are expected unless they are already receiving routine treatment. People age 12 and older may qualify. The study is recruiting at one listed site in United States.

Start date: August 21, 2026

Completion date: December 31, 2099

Organizer: CorEvitas

Contact: Vitiligo Registry Study Team

Tel.: 508-408-5531

Email: VITregistry@thermofisher.com

Link: https://clinicaltrials.gov/study/NCT07659418

Clinical Trial Alerts

Sign up and be the first to know about updates on this trial.

This request will be sent with the trial reference Long-term safety registry for vitiligo treatments . By submitting you agree to our Privacy Policy.

FAQOther Questions